Breast cancer is the most prevalent non-skin cancer diagnosed in females and developing
novel therapeutic strategies to improve patient outcomes is crucial. The immune system …

The proclivity of certain pre-malignant and pre-invasive breast lesions to progress while
others do not continues to perplex clinicians. Clinicians remain at a crossroads with …

The low overall survival rates of patients with breast cancer in sub-Saharan Africa (SSA) are
driven by regionally differing tumor biology, advanced tumor stages at diagnosis, and limited …

Pancreatic cancer is the third leading cause of cancer-related death in the United States.
Black or African American patients have a higher incidence of pancreatic cancer compared …

Background: the development and progression of triple-negative breast cancer (TNBC) is
driven by somatic driver mutations and the tumor-immune microenvironment. To date, data …

Improved strategies of cancer prevention and control have resulted in tangible benefits for
patients with cancer. Disparities in outcome have been reported as a result of inequal …

Breast cancer progression and metastasis involve the action of multiple transcription factors
in tumors and in the cells of the tumor microenvironment (TME) and understanding how …

Histones scaffold genomic DNA and regulate access to the transcriptional machinery.
However, naturally occurring histone variants can alter histone-DNA interactions, DNA and …

Introduction: The advent of immune checkpoint inhibitors marks significant progress in the
evolution of cancer treatment. Recent clinical trials have demonstrated the success of …

Abstract:" breast cancer" which is common type of carcinogenesis in females, surpassing
even bronchogenic cancer" accounting for approximately one-third of the registered female …